Homogenous enzyme immunoassay for cyclosporine in whole blood using the EMIT 2000 cyclosporine specific assay with the COBAS MIRA-plus analyzer
- PMID: 11793432
- PMCID: PMC6807697
- DOI: 10.1002/jcla.1044
Homogenous enzyme immunoassay for cyclosporine in whole blood using the EMIT 2000 cyclosporine specific assay with the COBAS MIRA-plus analyzer
Abstract
We describe the evaluation of the EMIT 2000 cyclosporine specific assay kit, an enzyme-multiplied immunoassay for cyclosporine in whole blood, with a COBAS MIRA-plus analyzer. The enzyme used for the assay was glucose-6-phosphate dehydrogenase (EC 1.1.1.49 G6PDH) from Leuconostoc mesenteroides; the monoclonal antibody is fairly specific for cyclosporine, and is not reactive with most metabolites. The assay principle is based on competitive immunoassay with G6PDH-labeled cyclosporine and cyclosporine in sample to the anticyclosporine mouse monoclonal antibody binding site. The within-assay coefficient of variation (CV) of this method was 2.7-4.2% (n = 10) at the levels of 56.2-339.7 microg/L. Day-to-day CVs ranged from 4.2-8.1% at the levels of 47.2-350.2 microg/L. The within-day CVs ranged from 2.0-6.4% at the levels of 43.3-330.5 microg/L. The functional detection limit was 24.9 microg/L. Samples treated with pretreatment reagent were stable at least 5 hr. Calibration was stable at least 10 days. The analytical recovery was 81-109%. The correlation between values obtained with the EMIT 2000 cyclosporine specific assay kit (y) and fluorescence polarization immunoassay (FPIA) (TDxFLx) (x) was: y = 0.880x - 13.053 microg/L (r = 0.984, Sy/x = 15.968, n = 71) with a mean difference of 31.42 +/- 19.89 microg/L ((TDxFLx - EMIT 2000) +/- SD); for the FPIA (AxSYM) (x): y = 0.989 - 4.144 microg/L (r = 0.981, Sy/x = 17.478, n = 71) with a mean difference of 5.56 +/- 17.38 microg/L ((AxSYM - EMIT 2000) +/- SD); and for the radioimmunoassay (RIA, CYCLO-Trac SP) (x): y = 0.893 - 6.764 microg/L (r = 0.993, Sy/x = 10.582, n = 71) with a mean difference of 22.18 +/- 14.98 microg/L ((RIA - EMIT 2000) +/- SD) using the Bland-Altman technique.
Copyright 2001 Wiley-Liss, Inc.
Similar articles
-
The EMIT Cyclosporine Assay: development of application protocols for the Boehringer Mannheim Hitachi 911 and 917 analyzers.Clin Biochem. 1997 Mar;30(2):155-62. doi: 10.1016/s0009-9120(96)00162-2. Clin Biochem. 1997. PMID: 9127698
-
Progress report of an external quality assessment scheme for cyclosporine assay.Ther Drug Monit. 1996 Jun;18(3):273-9. doi: 10.1097/00007691-199606000-00009. Ther Drug Monit. 1996. PMID: 8738767
-
Evaluation of EMIT Cyclosporine Assay for use with whole blood.Clin Chem. 1993 Nov;39(11 Pt 1):2235-41. Clin Chem. 1993. PMID: 8222215
-
Monitoring cyclosporin A (ciclosporin, INN) concentrations in whole blood: evaluation of the EMIT assay in comparison with HPLC and RIA.Eur J Clin Chem Clin Biochem. 1993 Jun;31(6):381-8. doi: 10.1515/cclm.1993.31.6.381. Eur J Clin Chem Clin Biochem. 1993. PMID: 8369366
-
Considerable lack of agreement between S-FPIA and EMIT cyclosporine assay in therapeutic drug monitoring, of heart transplant recipients.Ther Drug Monit. 2000 Dec;22(6):712-5. doi: 10.1097/00007691-200012000-00010. Ther Drug Monit. 2000. PMID: 11128239
Cited by
-
Immunoassay Methods and their Applications in Pharmaceutical Analysis: Basic Methodology and Recent Advances.Int J Biomed Sci. 2006 Sep;2(3):217-35. Int J Biomed Sci. 2006. PMID: 23674985 Free PMC article.
-
Utility, promise, and limitations of liquid chromatography-mass spectrometry-based therapeutic drug monitoring in precision medicine.J Mass Spectrom. 2021 Nov;56(11):e4788. doi: 10.1002/jms.4788. Epub 2021 Nov 4. J Mass Spectrom. 2021. PMID: 34738286 Free PMC article. Review.
References
-
- White DJG. 1982. Cyclosporin A: Clinical pharmacology and therapeutic potential. Drugs 24:322–334. - PubMed
-
- Stein CM, Murray JJ, Wood AJJ. 1999. Inhibition of stimulated interleukin‐2 production in whole blood: a practical measure of cyclosporine effect. Clin Chem 45:1477–1484. - PubMed
-
- Kalman VK, Klimpel GR. 1983. Cyclosporine A inhibits the production of gamma interferon (IFNγ) but does not inhibit production of virus‐induced IFNα/β . Cell Immunol 78:122–129. - PubMed
-
- Shaw LM, Kaplan B, Kaufman D. 1996. Toxic effects of immunosuppressive drugs: mechanisms and strategies for controlling them. Clin Chem 42:1316–1321. - PubMed
-
- Gupta SK, Benet LZ. 1989. HPLC measurement of cyclosporine in blood, plasma and urine and simultaneous measurement of its four metabolites in blood. J Liq Chromatogr 12:1451–1462.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources